Quarterly report [Sections 13 or 15(d)]

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of allowance for credit losses trade accounts receivable
       
Balance, net as of December 31, 2024   $ 239  
Charged to costs and expenses     179  
Recoveries     (39 )
Write-offs     (376 )
Balance, net as of December 31, 2025     3  
Charged to costs and expenses     3  
Balance, net as of March 31, 2026   $ 6  
Schedule of concentration of risk
   
  As of
  March 31, 2026 December 31, 2025
Customer A 19.8% *
Customer B 16.5% 26.1%
Customer C 14.8% *
Customer D 11.2% 11.1%
Customer E * 17.3%
* Less than 10%    

 

During the three months ended March 31, 2026, three customers each accounted for more than 10% of the Company’s total consolidated revenue. These customers accounted for an aggregate of 59.6% of the Company’s total revenue for the three months ended March 31, 2026. During the three months ended March 31, 2025, four customers each accounted for more than 10% of the Company’s total consolidated revenue. These customers accounted for an aggregate of 85.1% of the Company’s total revenue for the three months ended March 31, 2025.

  Three Months Ended March 31,
  2026 2025
Customer F 32.4% 17.9%
Customer G 15.3% 19.5%
Customer H 11.9% 16.0%
Customer A * 31.7%
* Less than 10%    
Schedule of marketable securities measured at fair value on a recurring basis
                       
    Level 1     Level 2     Total Fair Value  
Investments in Marketable Securities:                        
U.S. Treasury   $ 996     $     $ 996  
Total   $ 996     $     $ 996  
                         
Investment in Equity Interest:                        
Investment in YFE   $     $ 2,393     $ 2,393  
Total   $     $ 2,393     $ 2,393  
                         
Foreign Currency Forward Contracts:                        
Foreign Currency Forward Contracts, net:   $     $ (29 )   $ (29 )
Total   $     $ (29 )   $ (29 )

 

The following table presents the fair values of the Company's financial instruments measured on a recurring basis, categorized within the fair value hierarchy as of December 31, 2025 (in thousands):

    Level 1     Level 2     Total Fair Value  
Investments in Marketable Securities:                        
U.S. Treasury   $ 3,978     $     $ 3,978  
Total   $ 3,978     $     $ 3,978  
                         
Investment in Equity Interest:                        
Investment in YFE   $     $ 5,481     $ 5,481  
Total   $     $ 5,481     $ 5,481  
                         
Foreign Currency Forward Contracts:                        
Foreign Currency Forward Contracts, net:   $     $ (43 )   $ (43 )
Total   $     $ (43 )   $ (43 )